Custom-Made immune cells target stubborn lung cancer
Disease control
Terminated
This early-stage study tested a personalized treatment for advanced lung cancer that had stopped responding to standard immunotherapy. Doctors collected a patient's own tumor-fighting immune cells, grew them in a lab, and reinfused them along with other immune-boosting drugs. The…
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC